Cargando…

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score()

OBJECTIVE: To identify predictors of 30-day survival in elderly patients with coronavirus disease 2019 (COVID-19). METHODS: Retrospective cohort study including patients with COVID-19 aged ≥65 years hospitalized in six European sites (January 2020 to May 2021). Data on demographics, comorbidities, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiseo, Giusy, Margalit, Ili, Ripa, Marco, Borghi, Vanni, Green, Hefziba, Prendki, Virginie, Riccardi, Niccolò, Dishon, Yael, Perego, Giovanni Battista, Grembiale, Alessandro, Galli, Laura, Tinelli, Marco, Castagna, Antonella, Mussini, Cristina, Yahav, Dafna, Paul, Mical, Falcone, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523947/ https://www.ncbi.nlm.nih.gov/pubmed/36191845 http://dx.doi.org/10.1016/j.cmi.2022.09.019

Ejemplares similares

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group
por: Tiseo, Giusy, et al.
Publicado: (2021)

Caring for older adults during the COVID-19 pandemic
por: Prendki, Virginie, et al.
Publicado: (2022)

A systematic review assessing the under-representation of elderly adults in COVID-19 trials
por: Prendki, Virginie, et al.
Publicado: (2020)

Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
por: Paul, Mical, et al.
Publicado: (2023)

Long COVID-19—it's not over until?
por: Yelin, Dana, et al.
Publicado: (2021)

Pretomanid for tuberculosis treatment: an update for clinical purposes
por: Occhineri, Sara, et al.
Publicado: (2022)

Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study
por: Yelin, Dana, et al.
Publicado: (2022)

Skin and soft tissue infections in the elderly
por: Falcone, Marco, et al.
Publicado: (2023)

The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature
por: Margalit, Ili, et al.
Publicado: (2021)

Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization
por: Tiseo, Giusy, et al.
Publicado: (2023)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nave, Lior, et al.
Publicado: (2023)

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification
por: Falcone, Marco, et al.
Publicado: (2021)

Management of COVID patients with convalescent plasma: Do we have the final word?
por: Menichetti, Francesco, et al.
Publicado: (2022)

What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?
por: Tiseo, Giusy, et al.
Publicado: (2023)

Screening for Latent Tuberculosis Infection in Solid Organ Transplant Recipients to Predict Active Disease: A Systematic Review and Meta-Analysis of Diagnostic Studies
por: Yahav, Dafna, et al.
Publicado: (2023)

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
por: Russo, Alessandro, et al.
Publicado: (2020)

ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022)

Oral iron supplements for children in malaria‐endemic areas
por: Neuberger, Ami, et al.
Publicado: (2016)

Is shorter always better? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics
por: Yahav, Dafna, et al.
Publicado: (2022)

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis
por: Turjeman, Adi, et al.
Publicado: (2022)

Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians
por: Taddei, Riccardo, et al.
Publicado: (2023)

Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
por: Falcone, Marco, et al.
Publicado: (2021)

Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy
por: Falcone, Marco, et al.
Publicado: (2020)

External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA
por: Paul, Mical, et al.
Publicado: (2015)

Risk-factors for re-admission and outcome of patients hospitalized with confirmed COVID-19
por: Green, Hefziba, et al.
Publicado: (2021)

Monitoring renal function during combination therapy with telaprevir in HIV/HCV co-infected patients with advanced/fibrosis cirrhosis
por: Puzzolante, Cinzia, et al.
Publicado: (2014)

Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020
por: Falcone, Marco, et al.
Publicado: (2020)

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae–Producing KPC-31, a D179Y Variant of KPC-3
por: Tiseo, Giusy, et al.
Publicado: (2021)

1650. Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap
por: Abdelraouf, Kamilia, et al.
Publicado: (2022)

The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study
por: Yahav, Dafna, et al.
Publicado: (2019)

Point-of-Care Ultrasound to Diagnose a Simple Ranula
por: Margalit, Ili, et al.
Publicado: (2016)

Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis
por: Daitch, Vered, et al.
Publicado: (2022)

COVID-19 in special populations
por: Yahav, Dafna
Publicado: (2022)

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015)

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021)

Predictors and outcomes of respiratory bacterial coinfections in patients with COVID‐19 admitted to hospital: An observational prospective study
por: Tiseo, Giusy, et al.
Publicado: (2022)

The unique COVID-19 presentation of patients with B cell depletion: author's response
por: Belkin, Ana, et al.
Publicado: (2023)

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
por: Falcone, Marco, et al.
Publicado: (2020)

Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study
por: Yahav, Dafna, et al.
Publicado: (2022)

Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
por: Bukan, Katrine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q69dqrmoa21lp8csg5d0uq5ljn